TLK286: Phase I

Interim results from an ongoing U.S. open label dose escalation Phase I trial

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE